Purchase Order 75D30121P12462
- Not listed
- This is a firm-fixed price delivery order awarded by the Department of the Air Force Air Education and Training Command to Biomerieux Inc., a foreign-owned for-profit manufacturer of diagnostic goods. The $103,729.72 contract is for the provision of microbiology reagents and supplies, with a period of performance through September 30, 2022. Biomerieux Inc. is a global leader in in vitro diagnostics, offering solutions for medical and industrial microbiology testing. The company has an...
- This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Biomerieux Inc., a global leader in in vitro diagnostics, for critical functions. The contract, valued at $180,000.00, is a firm-fixed-price award with a period of performance through September 3, 2015. The contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, provides a range of clinical diagnostic equipment,...
- This firm-fixed-price delivery order was awarded by a U.S. government agency to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of its proprietary BioMerieux products. The $56,200 contract is for BioMerieux's specialized clinical diagnostic equipment, reagents, and supplies, including automated microbial identification systems, antibiotic susceptibility testing platforms, and molecular diagnostic technologies. The award was made under Biomerieux's Federal Supply...
- This $3,271,440.00 firm-fixed-price definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a global in vitro diagnostics company, for BIONUMERICS SUPPORT services. The contract has a period of performance through July 31, 2025 and does not involve any set-aside designations. Biomerieux Inc., through its Biomerieux, Inc. division, is a leading provider of specialized clinical diagnostic equipment, reagents, and supplies to various federal...
- This federal contract was awarded by the Department of the Air Force Air Education and Training Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of microbiology reagents and supplies. The $103,729.72 firm fixed-price delivery order has a completion date of September 30, 2019. Biomerieux Inc. is a global leader in in vitro diagnostics, offering solutions for medical and industrial microbiology applications. The company has an active Indefinite...
- This $212,471.20 firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic solutions. The contract is for the provision of Biomerieux's proprietary microbiology analyzer equipment, reagents, and technical support services to enable infectious disease testing and identification. This award is associated with Biomerieux's existing indefinite delivery contracts and blanket purchase agreements...
- This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Biomerieux Inc., a global leader in in vitro diagnostics and microbiological testing solutions. The $22,676.72 contract is for the delivery of Biomerieux's proprietary diagnostic equipment, reagents, and supplies, such as their VITEK, BioFire, and VIDAS systems, which are used for rapid pathogen detection and identification. Biomerieux supports various federal agencies, including the...
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods, for VCI SCAN RDI NEW GENERATION with a completion date of September 30, 2018. The potential value of the contract is $321,220.99. The contract was not set aside for any specific business category. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, providing...
- The Department of the Air Force Materiel Command awarded a Blanket Purchase Agreement (BPA) call to Biomerieux Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic substances, reagents, test kits, and sets. The $125,331.41 firm fixed-price contract, awarded on October 1, 2017, is for the provision of these clinical diagnostic products and services to support infectious disease testing and analysis. Biomerieux Inc. is an experienced federal contractor, holding multiple active...
- This is a federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, for the purchase of a VITEK 2 lab equipment by the Centers for Disease Control and Prevention (CDC). The firm-fixed-price delivery order, valued at $95,857.00, is placed under the CDC's Scientific Equipment and Services (FSS-66) Federal Supply Schedule contract. The contract does not have a set-aside designation. Biomerieux, through its Biomerieux, Inc. division, specializes in microbiological testing...
This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Biomerieux Inc., a global leader in in vitro diagnostics. The $16,822.90 contract is for the supply of Biomerieux reagents and supports CDC operations in Atlanta, Georgia. Biomerieux is a manufacturer of clinical diagnostic equipment, reagents, and supplies used for infectious disease testing and pathogen detection across healthcare, food safety, and industrial testing programs. The company holds numerous federal contracts and indefinite delivery vehicles with agencies like the Department of Veterans Affairs, Department of Defense, and Department of Agriculture to provide its proprietary microbiology analysis platforms and associated consumables. This award is not designated as a set-aside procurement. Biomerieux also receives federal grant funding, including a sub-grant for laboratory equipment repair services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Other Administrative Action | ($240) | 6/29/24 | |
| Not listed | Not listed | $16.8k | 8/26/21 |